Pharma MSMEs hit by inverted duty: Pharmexcil
Pharmaceutical MSMEs are grappling with accumulated input tax credit (ITC) in the wake of GST 2.0 reforms coming to significantly aggravate the issue of inverted duty structure.
2 May 13:53 · The Hindu
Inverted duty pinching pharma MSMEs, road ahead tough, says Pharmexcil
Pharmaceutical MSMEs are grappling with accumulated input tax credit (ITC) in the wake of GST 2.0 reforms coming to significantly aggravate the issue of inverted duty structure.
2 May 13:53 · The Hindu
last updated on 2 May 16:27